GESYNTA PHARMA
Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study, GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positi... ve results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
GESYNTA PHARMA
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.gesynta.se
Total Employee:
1+
Status:
Active
Contact:
559103-6628
Email Addresses:
[email protected]
Total Funding:
27.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Altamira Therapeutics
Altamira Therapeutics develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Closed Loop Medicine
Developing personalised digital healthcare solutions to improve outcomes for patients and clinicians
Stoke Therapeutics
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Synapse Medicine
Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.
Current Employees Featured
Founder
Investors List
Hadean Ventures
Hadean Ventures investment in Series C - Gesynta Pharma
Industrifonden
Industrifonden investment in Series C - Gesynta Pharma
Linc AB
Linc AB investment in Series C - Gesynta Pharma
Industrifonden
Industrifonden investment in Seed Round - Gesynta Pharma
Official Site Inspections
http://www.gesynta.se
- Host name: solnabergproperty.com
- IP address: 81.170.239.161
- Location: Stockholm Sweden
- Latitude: 59.3307
- Longitude: 18.0718
- Timezone: Europe/Stockholm
- Postal: 110 57
More informations about "Gesynta Pharma"
Gesynta
Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates …See details»
Gesynta Pharma - Crunchbase Company Profile & Funding
Gesynta Pharma is a clinical stage pharmaceutical company, developing a portfolio of …See details»
Gesynta Pharma 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Gesynta Pharma. …See details»
Gesynta Pharma AB - Företagsinformation - allabolag.se
Gesynta Pharma AB,559103-6628 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, …See details»
Gesynta Pharma AB - Develops Novel Antiinflammatory And Pain …
Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates …See details»
Gesynta Pharma - KI Innovations
Gesynta är ett läkemedelsbolag med meriterade forskare från Karolinska Institutet och ett team …See details»
Gesynta Pharma – 20 Years of Innovation
Jan 22, 2021 LÄKEMEDEL På jakt efter bättre bot vid inflammation LÄKEMEDEL Under 2020 …See details»
Gesynta – Industrifonden
Gesynta Pharma develops novel anti-inflammatory, pain-relieving pharmaceuticals. The …See details»
Gesynta Pharma - Craft
Gesynta Pharma is a company operating in the fields of mPGES-1 medical research, drug …See details»
Gesynta Pharma
Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates …See details»
Our history - Gesynta
Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates …See details»
Gesynta Pharma – NOME
Gesynta Pharma is a biotech company developing treatments based on mPGES-1 inhibitor for …See details»
Gesynta Pharma - SwedenBIO
Gesynta Pharma's most advanced drug candidate, vipoglanstat, is in clinical phase II …See details»
Gesynta Pharma Raises $29M to Advance Non-Hormonal …
Jan 20, 2025 Swedish biotech Gesynta Pharma has secured SEK 304 million ($29 million) in …See details»
Gesynta Pharma Company Information - Funding, Investors, and …
Get information on funding, investors, industries, and more for Gesynta Pharma. See Gesynta …See details»
Series B - Gesynta Pharma - 2025-01-20 - Crunchbase
Jan 20, 2025 Gesynta Pharma raised $27270688 on 2025-01-20 in Series BSee details»
Gesynta Pharma Raises SEK 304 Million to Advance Novel
STOCKHOLM, SWEDEN - January 20, 2025. Gesynta Pharma AB announces that it has …See details»
Life Science fund leads SEK 304 million Series B financing round …
Jan 20, 2025 Gesynta Pharma AB has secured SEK 304 million in a Series B financing round …See details»
€18M to Fund Gesynta's First-in-Class Systemic Sclerosis Drug
Jul 9, 2020 Swedish biotech Gesynta Pharma raised €18.2M (SEK 190M) in a placement …See details»
Gesynta Pharma Raises SEK 304 Million to Advance Novel …
Jan 20, 2025 Gesynta Pharma has secured SEK 304 million in a Series B financing. The …See details»